Joseph W. Turgeon
CIK 1574659 · CEO & President · last filed 2021-03-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
SPPI price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
HENDERSON, NV 89052
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | CEO & President | 566,566 | $1.03 | $583.6K | -$3.04M | 38 | 2021-03-17 |
Recent Filings · Page 2 of 4
38 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-17 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −22,702 | -$193.8K | EDGAR |
| 2019-03-29 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −6,307 | -$67.2K | EDGAR |
| 2019-03-25 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −5,315 | -$50.3K | EDGAR |
| 2019-02-20 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +75,000 | $0 | EDGAR |
| 2019-01-18 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −5,091 | -$53.1K | EDGAR |
| 2019-01-11 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Mixed | +97,123 | -$394.8K | EDGAR |
| 2018-04-18 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −11,565 | -$219.8K | EDGAR |
| 2018-03-28 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −4,810 | -$78.9K | EDGAR |
| 2018-03-23 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Sell (S) | −3,100 | -$56.3K | EDGAR |
| 2018-01-19 | SPECTRUM PHARMACEUTICALS INC (SPPI) Delisted | Grant (A) | +38,889 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.